PATENT CLAIM ANALYSIS

Application Number: 15990228
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["514", "171000"]

Abstract:
The present disclosure relates to compositions, methods and devices for treating, reducing or preventing one or more eye disorders, particularly dry eye disorders, in a subject by administering an amount of one or more fatty acids and/or fatty acid esters therapeutically effective to inhibit lipase activity while permitting bacterial growth or without substantially altering the dynamic microbial community of the eye. Typically, the fatty acids and/or fatty acid esters are C 8  to C 16  fatty acids and/or fatty acid esters.

Claim (Index 7):
A composition according to  claim 6  wherein the androgen and/or androgen analogue is selected from one or more of the following: dehydroepiandrosterone (DHEA), androsterone, testosterone and dihydrotestosterone.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 93.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14414030', '12601676', '13264659', '12655240', '14775452']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7030976955710168
- 35 USC 102 Novelty (BERT): 0.5648545473212307
- Combined Prediction Score: 0.6892733807460382
- Mean Citation Score: 251.457532
- Max Citation Score: 474.20673
- Similarity Product: 283.6249986131823

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test